Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer

Salinomycin (Sal) is a recently identified anti-tumor drug for treating several types of solid tumor; however, its effects on the migratory and invasive properties of non-small cell lung cancer (NSCLC) remain unclear. This study investigated the inhibitory effect underlying mechanisms of Salon trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ki-Eun, Kim, Hyo-Jin, Song, In-Sol, Park, Chul, Jung, Jae Wan, Park, Do-Sim, Oh, Seon-Hee, Kim, Young-Suk, Kim, Hak-Ryul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797542/
https://www.ncbi.nlm.nih.gov/pubmed/33437206
http://dx.doi.org/10.7150/ijms.50080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797542/
https://www.ncbi.nlm.nih.gov/pubmed/33437206
http://dx.doi.org/10.7150/ijms.50080

Ejemplares similares